<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04906356</url>
  </required_header>
  <id_info>
    <org_study_id>H18-03039</org_study_id>
    <nct_id>NCT04906356</nct_id>
  </id_info>
  <brief_title>Canadian SCAD Study</brief_title>
  <official_title>Canadian Spontaneous Coronary Artery Dissection (SCAD) Study and Genetic Sub-study (Prospective, Observational Registry With 10 Year Follow-up)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiology Research UBC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>John GB Mancini, MD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karin Humphries, DSc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardiology Research UBC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Natural history multicenter, prospective, observational registry with 10-year follow-up&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spontaneous coronary artery dissection (SCAD) is an under-diagnosed and poorly understood&#xD;
      condition that frequently affects young women without conventional cardiovascular (CV) risk&#xD;
      factors and can result in myocardial infarction (MI), cardiac arrest, and death. This&#xD;
      condition has not been adequately studied, and there are no randomized controlled trials to&#xD;
      guide treatment. Furthermore, SCAD has been frequently misdiagnosed due to the current&#xD;
      &quot;gold-standard&quot; coronary angiography limitations. As such, there are uncertainties with the&#xD;
      diagnosis and management of SCAD patients. Therefore, the investigators propose a large&#xD;
      prospective multicenter Canadian SCAD Study to ascertain the natural history of predisposing&#xD;
      arteriopathies and treatment strategy on short and long-term CV outcomes to design future&#xD;
      randomized controlled trials.&#xD;
&#xD;
      This is a multicenter, prospective, international, observational natural history study with a&#xD;
      planned total enrolment of 3,000 patients with SCAD. The investigators plan to recruit&#xD;
      patients from major cardiac catheterization centers across Canada and several centers in the&#xD;
      United States and internationally. The research team successfully enrolled 750 patients&#xD;
      prospectively in the &quot;Canadian SCAD Cohort Study&quot; from 22 sites in North America. This&#xD;
      current study will be an extension of that study, now named the &quot;Canadian SCAD Study.&quot; It&#xD;
      will continue enrolment for a total of 3,000 patients internationally (from &gt;35 sites).&#xD;
      Detailed baseline demographics, targeted history for precipitating stressors and predisposing&#xD;
      conditions, and investigations for predisposing conditions will be performed during the&#xD;
      study. Patients will be prospectively followed long-term for up to 10 years for CV events.&#xD;
      The study is approved, allowing potential participants to be enrolled using an electronic&#xD;
      consent form irrespective of their geographic location and directly communicating with the&#xD;
      study team at UBC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2033</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2033</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital CV outcomes</measure>
    <time_frame>From date of hospital admission to discharge up to 8 weeks</time_frame>
    <description>Composite (Death, MI, CVA, Unplanned revascularization, Heart failure)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term CV outcomes</measure>
    <time_frame>at 10 Years post index event</time_frame>
    <description>Composite (Death, MI, CVA, Revascularization, Heart failure)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial healing post SCAD</measure>
    <time_frame>at 6 weeks post discharge post index event</time_frame>
    <description>Angiographic healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronary revascularization success</measure>
    <time_frame>During index hospitalization</time_frame>
    <description>Composite (TIMI 3 flow, &lt;50% stenosis, and no residual dissection)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Spontaneous Coronary Artery Dissection</condition>
  <condition>SCAD</condition>
  <condition>Fibromuscular Dysplasia</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>Single group observational study</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Genetic sub-study</intervention_name>
    <description>One time saliva sample collection</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva DNA sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted with ACS (STEMI, NSTEMI or unstable angina) and diagnosed with SCAD&#xD;
        during direct coronary angiography. The study imaging corelab will review all films before&#xD;
        participant enrollment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients admitted with ACS (STEMI, NSTEMI or unstable angina)&#xD;
&#xD;
          2. Documented SCAD on a coronary angiogram (including diagnosis with OCT or IVUS)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Patients where SCAD is attributed to atherosclerotic coronary artery disease, with&#xD;
        atherosclerotic coronary artery disease stenosis â‰¥50%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacqueline Saw, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiology Research UBC / Vancouver General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Starovoytov, MD</last_name>
    <phone>6048755079</phone>
    <email>a.starovoytov@ubc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Johandra Argote Parolis, MD</last_name>
    <phone>6048754111</phone>
    <phone_ext>63344</phone_ext>
    <email>j.argoteparolis@ubc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johandra Argote Parolis, MD</last_name>
      <phone>604 875 4111</phone>
      <phone_ext>63344</phone_ext>
      <email>j.argoteparolis@ubc.ca</email>
    </contact>
    <investigator>
      <last_name>Jacqueline Saw, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John GB Mancini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Saw J, Starovoytov A, Humphries K, Sheth T, So D, Minhas K, Brass N, Lavoie A, Bishop H, Lavi S, Pearce C, Renner S, Madan M, Welsh RC, Lutchmedial S, Vijayaraghavan R, Aymong E, Har B, Ibrahim R, Gornik HL, Ganesh S, Buller C, Matteau A, Martucci G, Ko D, Mancini GBJ. Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes. Eur Heart J. 2019 Apr 14;40(15):1188-1197. doi: 10.1093/eurheartj/ehz007.</citation>
    <PMID>30698711</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiology Research UBC</investigator_affiliation>
    <investigator_full_name>Jacqueline Saw, MD</investigator_full_name>
    <investigator_title>Clinical Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Fibromuscular displasia (FMD)</keyword>
  <keyword>Myocardial Infarction</keyword>
  <keyword>Myocardial Infarction in women</keyword>
  <keyword>Non-atherosclerotic coronary artery disease (NACAD)</keyword>
  <keyword>Myocardial Infarction with no obstructive coronary artery disease (MINOCA)</keyword>
  <keyword>SCAD</keyword>
  <keyword>Spontaneous Coronary Artery Dissection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
    <mesh_term>Coronary Vessel Anomalies</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Fibromuscular Dysplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

